www.fgks.org   »   [go: up one dir, main page]

( Log in to your Wikimedia account to use OAuth instead of Quickstatements for updates.)

Author Wikidata ID:
Additional SPARQL filters separated by semicolons (eg. for papers on Zika virus, enter wdt:P921 wd:Q202864):

Federico Rojo

Wikidata Item | Scholia Profile [curation] | Reasonator | SQID

Listed Publications

Warning: limit reached; query again or adjust the limit parameter if you need to see more papers from this author.

50 publications found

TitleAuthors (identified)Published InIdentifier(s)TopicPublished Date
PD-L1 testing based on SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion[1]Vicente Peg, [2]María Ángeles López-García, [3]Laura Comerma, [4]Gloria Peiró, [5]Tomás García-Caballero, [6]Ángel Concha López, [7]Ana Suárez-Gauthier, [8]Irune Ruiz, [9]Federico Rojo [Full author list]Future Oncology [curation]DOI: 10.2217/FON-2020-1100
PubMed: 33289433
2020-12-08
Prognostic implications of markers of the metabolic phenotype in human cutaneous melanoma[1]Laura Najera, [2]Miguel Alonso Juarranz, [3]M Garrido, [4]C Ballestín, [5]L Moya, [6]M Martínez-Díaz, [7]R Carrillo, [8]Angeles Juarranz, [9]Federico Rojo, [10]José M Cuezva, [11]José Luis Rodríguez-Peralto [Full author list]British Journal of Dermatology [curation]DOI: 10.1111/BJD.17513
PubMed: 30537064
2019-03-18
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study[1]Alberto Ocana, [2]Marta Gil-Martin, [3]Silvia Antolín, [4]María Atienza, [5]Álvaro Montaño, [6]Nuria Ribelles, [7]Ander Urruticoechea, [8]Alejandro Falcón, [9]Sonia Pernas, [10]Javier Orlando, [11]Juan Carlos Montero, [12]Maria José Escudero, [13]Sara Benito, [14]Rosalía Caballero, [15]Eva Carrasco, [16]Federico Rojo, [17]Atanasio Pandiella, [18]Manuel Ruiz-Borrego [Full author list]Breast Cancer Research and Treatment [curation]DOI: 10.1007/S10549-018-05100-Z
PubMed: 30607629
trastuzumab [curation]; dasatinib [curation]; paclitaxel [curation]; metastatic breast cancer [curation]; dasatinib monohydrate [curation]2019-01-03
NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival[1]Aura Muntasell, [2]Federico Rojo, [3]Sonia Servitja, [4]Carlota Rubio-Perez, [5]Mariona Cabo, [6]David Tamborero, [7]Marcel Costa-Garcia, [8]Maria Martinez Garcia, [9]Sílvia Menéndez, [10]Ivonne Vazquez, [11]Ana Lluch, [12]Abel Gonzalez-Perez, [13]Ana Rovira, [14]Miguel López-Botet, [15]Joan Albanell [Full author list]Clinical Cancer Research [curation]DOI: 10.1158/1078-0432.CCR-18-2365
PubMed: 30523021
2018-12-06
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer[1]Jesús García-Foncillas, [2]Josep Tabernero, [3]Elena Élez, [4]Enrique Aranda, [5]Manuel Benavides, [6]Carlos Camps, [7]Eloisa Jantus Lewintre, [8]Rafael López, [9]Laura Muinelo-Romay, [10]Clara Montagut, [11]Antonio Antón, [12]Guillermo López, [13]Eduardo Díaz-Rubio, [14]Federico Rojo, [15]Ana Vivancos [Full author list]British Journal of Cancer [curation]DOI: 10.1038/S41416-018-0293-5
PubMed: 30467411
colorectal cancer [curation]; metastatic colon cancer [curation]2018-11-23
Analysis of Potential Alterations Affecting SETBP1 as a Novel Contributing Mechanism to Inhibit PP2A in Colorectal Cancer Patients[1]Blanca Torrejón, [2]Ion Cristóbal, [3]Cristina Caramés, [4]Iván Prieto-Potín, [5]Cristina Chamizo, [6]Andrea Santos, [7]Marta Sanz-Alvarez, [8]Roberto Serna-Blasco, [9]Melania Luque, [10]Juan Madoz-Gúrpide, [11]Federico Rojo, [12]Jesús García-Foncillas [Full author list]World Journal of Surgery [curation]DOI: 10.1007/S00268-018-4684-9
PubMed: 29796729
colorectal cancer [curation]2018-11-01
Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology[1]Ramon Colomer, [2]I Aranda-López, [3]J Albanell, [4]T García-Caballero, [5]E Ciruelos, [6]M Á López-García, [7]J Cortés, [8]Federico Rojo, [9]M Martín, [10]J Palacios-Calvo [Full author list]Clinical and Translational Oncology [curation]DOI: 10.1007/S12094-018-1909-1
PubMed: 29916189
biomarker [curation]; medical oncology [curation]2018-08-01
Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer[1]Iván Prieto-Potin, [2]Clara Montagut, [3]Beatriz Bellosillo, [4]Matthew Evans, [5]Matthew Smith, [6]Linea Melchior, [7]Werner Reiltin, [8]Michael Bennett, [9]Veronica Pennati, [10]Francesca Castiglione, ..., [25]Mohammed Alorini, [26]Jean-Christophe Sabourin, [27]Federico Rojo [Full author list]The Journal of Molecular Diagnostics [curation]DOI: 10.1016/J.JMOLDX.2018.05.008
PubMed: 29959022
colorectal cancer [curation]; metastatic colon cancer [curation]2018-06-26
A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012-12 (EDALINE) study[1]Manuel Ruiz-Borrego, [2]Begoña Jimenez, [3]Silvia Antolín, [4]Jose A Garcia-Saenz, [5]Jesús Corral, [6]Yolanda Jerez, [7]José Trigo, [8]Ander Urruticoechea, [9]Helena Colom, [10]Nuria Gonzalo, [11]Carmen Muñoz, [12]Sara Benito, [13]Rosalía Caballero, [14]Susana Bezares, [15]Eva Carrasco, [16]Federico Rojo, [17]Miguel Martin [Full author list]Investigational New Drugs [curation]DOI: 10.1007/S10637-018-0614-9
PubMed: 29948356
docetaxel [curation]2018-06-09
Potential Therapeutic Impact of miR-145 Deregulation in Colorectal Cancer[1]Ion Cristóbal, [2]Marta Sanz-Alvarez, [3]Blanca Torrejón, [4]Andrea Santos, [5]Melani Luque, [6]Federico Rojo, [7]Jesús García-Foncillas [Full author list]Molecular Therapy [curation]DOI: 10.1016/J.YMTHE.2018.05.008
PubMed: 29778522
colorectal cancer [curation]2018-05-18
Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer[1]Ion Cristóbal, [2]Blanca Torrejón, [3]Andrea Santos, [4]Melani Luque, [5]Marta Sanz-Alvarez, [6]Federico Rojo, [7]Jesús García-Foncillas [Full author list]European Journal of Surgical Oncology [curation]DOI: 10.1016/J.EJSO.2018.04.021
PubMed: 29778618
colorectal cancer [curation]; metastatic colon cancer [curation]2018-05-09
Comment on 'MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma'[1]Ion Cristóbal, [2]Andrea Santos, [3]Silvia González, [4]Melania Luque, [5]Blanca Torrejón, [6]Federico Rojo, [7]Jesús García-Foncillas [Full author list]British Journal of Cancer [curation]DOI: 10.1038/S41416-018-0013-1
PubMed: 29551773
2018-03-19
[Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology][1]José Palacios Calvo, [2]Joan Albanell, [3]Federico Rojo, [4]Eva Ciruelos, [5]Ignacio Aranda-López, [6]Javier Cortés, [7]Tomás García-Caballero, [8]Miguel Martín, [9]María Ángeles López-García, [10]Ramon Colomer [Full author list]Revista Española de Patología [curation]DOI: 10.1016/J.PATOL.2017.12.002
PubMed: 29602380
biomarker [curation]; medical oncology [curation]2018-03-14
2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications[1]Nieves González, [2]Isabel Prieto, [3]Laura Del Puerto-Nevado, [4]Sergio Portal-Nuñez, [5]Juan Antonio Ardura, [6]Marta Cortón, [7]Beatriz Fernández-Fernández, [8]Oscar Aguilera, [9]Carmen Gomez-Guerrero, [10]Sebastian Mas, ..., [13]Ana B Sanz, [14]Maria Dolores Sanchez-niño, [15]Federico Rojo, [16]Fernando Vivanco, [17]Pedro Esbrit, ... [Full author list]Oncotarget [curation]DOI: 10.18632/ONCOTARGET.14472
PubMed: 28060743
epidemiology [curation]; colorectal cancer [curation]; type 2 diabetes [curation]; colorectal carcinoma [curation]; colorectal neoplasm [curation]2017-03-14
Colon cancer modulation by a diabetic environment: A single institutional experience[1]Isabel Prieto, [2]Laura Del Puerto-Nevado, [3]Nieves Gonzalez, [4]Sergio Portal-Nuñez, [5]Sandra Zazo, [6]Marta Cortón, [7]Pablo Minguez, [8]Carmen Gomez-Guerrero, [9]Jose Miguel Arce, [10]Ana B Sanz, [11]Sebastian Mas, [12]Oscar Aguilera, [13]Gloria Alvarez-Llamas, [14]Pedro Esbrit, [15]Alberto Ortiz, [16]Carmen Ayuso, [17]Jesus Egido, [18]Federico Rojo, [19]Jesus Garcia-Foncillas, [20]DiabetesCancerConnect Consortium [Full author list]PLOS One [curation]DOI: 10.1371/JOURNAL.PONE.0172300
PubMed: 28253286
colon cancer [curation]2017-03-02
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer[1]Aranzazu Fernandez-Martinez, [2]Tomás Pascual, [3]Giuseppe Perrone, [4]Serafin Morales, [5]Juan de la Haba, [6]Milagros González-Rivera, [7]Patricia Galván, [8]Francesca Zalfa, [9]Michela Amato, [10]Lucia Gonzalez, [11]Miquel Prats, [12]Federico Rojo, [13]Luis Manso, [14]Laia Paré, ... [Full author list]Oncotarget [curation]DOI: 10.18632/ONCOTARGET.15748
PubMed: 28423537
2017-03-01
CIP2A confirms its prognostic value in triple-negative breast cancer[1]I Cristóbal, [2]S Zazo, [3]B Torrejón, [4]M Pedregal, [5]J Madoz-Gúrpide, [6]Ana Lluch, [7]P Eroles, [8]A Rovira, [9]J Albanell, [10]J García-Foncillas, [11]Federico Rojo [Full author list]Oncogene [curation]DOI: 10.1038/ONC.2016.474
PubMed: 28068327
triple-negative breast cancer [curation]2017-01-09
PP2A plays a key role in inflammation and cancer through tristetraprolin activation[1]Ion Cristóbal, [2]Blanca Torrejón, [3]Juan Madoz-Gúrpide, [4]Federico Rojo, [5]Jesús García-Foncillas [Full author list]Annals of the Rheumatic Diseases [curation]DOI: 10.1136/ANNRHEUMDIS-2016-210684
PubMed: 27811146
2016-11-03
Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma[1]Federico Rojo, [2]Abel Gonzalez-Perez, [3]Jessica Furriol, [4]Ma Jesús Nicolau, [5]Jaime Ferrer, [6]Octavio Burgués, [7]MohammadA Sabbaghi, [8]Irene González-Navarrete, [9]Ion Cristobal, [10]Laia Serrano, [11]Sandra Zazo, [12]Juan Madoz, [13]Sonia Servitja, [14]Ignasi Tusquets, [15]Joan Albanell, [16]Ana Lluch, [17]Ana Rovira, [18]Pilar Eroles [Full author list]British Journal of Cancer [curation]DOI: 10.1038/BJC.2016.204
PubMed: 27404455
estrogen [curation]; NF-κB [curation]; breast carcinoma [curation]2016-07-12
Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications[1]Ion Cristóbal, [2]Federico Rojo, [3]Juan Madoz-Gúrpide, [4]Jesús García-Foncillas [Full author list]Molecular and Cellular Biology [curation]DOI: 10.1128/MCB.00130-16
PubMed: 27090640
prostate cancer [curation]2016-05-31
Deregulation of miR-92a in locally advanced rectal cancer[1]Ion Cristóbal, [2]Blanca Torrejón, [3]Juan Madoz-Gúrpide, [4]Federico Rojo, [5]Jesús García-Foncillas [Full author list]Genes, Chromosomes and Cancer [curation]DOI: 10.1002/GCC.22357
PubMed: 27015298
2016-05-02
FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth[1]Felipe Slebe, [2]Federico Rojo, [3]Maria Vinaixa, [4]Mar García-Rocha, [5]Giorgia Testoni, [6]Marc Guiu, [7]Evarist Planet, [8]Sara Samino, [9]Enrique J Arenas, [10]Antoni Beltran, [11]Ana Rovira, [12]Ana Lluch, [13]Xavier Salvatella, [14]Oscar Yanes, [15]Joan Albanell, [16]Joan J Guinovart, [17]Roger Gomis [Full author list]Nature Communications [curation]DOI: 10.1038/NCOMMS11199
PubMed: 27045898
endothelium [curation]2016-04-05
Clinical Usefulness of 5-FU Metabolic Enzymes as Predictive Markers of Response to Chemotherapy in Colorectal Cancer[1]Ion Cristóbal, [2]Rebeca Manso, [3]Paula González-Alonso, [4]Juan Madoz-Gurpide, [5]Federico Rojo, [6]Jesús García-Foncillas [Full author list]World Journal of Surgery [curation]DOI: 10.1007/S00268-015-3176-4
PubMed: 26228063
colorectal cancer [curation]2016-04-01
Downregulation of miR-138 as a Contributing Mechanism to Lcn-2 Overexpression in Colorectal Cancer with Liver Metastasis[1]Ion Cristóbal, [2]Blanca Torrejón, [3]Paula González-Alonso, [4]Rebeca Manso, [5]Federico Rojo, [6]Jesús García-Foncillas [Full author list]World Journal of Surgery [curation]DOI: 10.1007/S00268-015-3241-Z
PubMed: 26316117
colorectal cancer [curation]; liver metastasis [curation]; colorectal carcinoma [curation]2016-04-01
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer[1]Emilio Alba, [2]Ana Lluch, [3]Nuria Ribelles, [4]Antonio Anton-Torres, [5]Pedro Sanchez-Rovira, [6]Joan Albanell, [7]Lourdes Calvo, [8]Jose Antonio Lopez García-Asenjo, [9]Jose Palacios, [10]Jose Ignacio Chacon, ..., [19]Rosalía Caballero, [20]Eva Carrasco, [21]Federico Rojo [Full author list]Oncologist [curation]DOI: 10.1634/THEONCOLOGIST.2015-0312
PubMed: 26786263
chemotherapy [curation]2016-01-19
Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer[1]Cristina Chamizo, [2]Sandra Zazo, [3]Manuel Dómine, [4]Ion Cristóbal, [5]Jesús García-Foncillas, [6]Federico Rojo, [7]Juan Madoz-Gúrpide [Full author list]BMC Pulmonary Medicine [curation]DOI: 10.1186/S12890-015-0132-X
PubMed: 26502926
biomarker [curation]; non-small-cell lung carcinoma [curation]2015-10-26
Clinical Value of miR-26b Discriminating Ulcerative Colitis-associated Colorectal Cancer in the Subgroup of Patients with Metastatic Disease[1]Ion Cristóbal, [2]Rebeca Manso, [3]Paula Gónzález-Alonso, [4]Juan Madoz-Gúrpide, [5]Federico Rojo, [6]Jesús García-Foncillas [Full author list]Inflammatory Bowel Diseases [curation]DOI: 10.1097/MIB.0000000000000572
PubMed: 26308439
colorectal cancer [curation]2015-10-01
Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis[1]Milica Pavlovic, [2]Anna Arnal-Estapé, [3]Federico Rojo, [4]Anna Bellmunt, [5]Maria Tarragona, [6]Marc Guiu, [7]Evarist Planet, [8]Xabier Garcia-Albéniz, [9]Mónica Morales, [10]Jelena Urosevic, [11]Sylwia Gawrzak, [12]Ana Rovira, [13]Aleix Prat, [14]Lara Nonell, [15]Ana Lluch, [16]Joël Jean-Mairet, [17]Robert Coleman, [18]Joan Albanell, [19]Roger Gomis [Full author list]Journal of the National Cancer Institute [curation]DOI: 10.1093/JNCI/DJV256
PubMed: 26376684
2015-09-15
Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer[1]Juan Madoz-Gúrpide, [2]Sandra Zazo, [3]Cristina Chamizo, [4]Victoria Casado, [5]Cristina Caramés, [6]Eduardo Gavín, [7]Ion Cristóbal, [8]Jesús García-Foncillas, [9]Federico Rojo [Full author list]Journal of Translational Medicine [curation]DOI: 10.1186/S12967-015-0633-7
PubMed: 26319934
cetuximab [curation]; head and neck cancer [curation]; head and neck carcinoma [curation]; neck cancer [curation]2015-08-29
Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma[1]Paula González-Alonso, [2]Cristina Chamizo, [3]Víctor Moreno, [4]Juan Madoz-Gúrpide, [5]Nerea Carvajal, [6]Lina Daoud, [7]Sandra Zazo, [8]Ester Martín-Aparicio, [9]Ion Cristóbal, [10]Raúl Rincón, [11]Jesús García-Foncillas, [12]Federico Rojo [Full author list]International Journal of Molecular Sciences [curation]DOI: 10.3390/IJMS160819447
PubMed: 26287187
pyrosequencing [curation]2015-08-17
Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors[1]José Yélamos, [2]Miguel Galindo, [3]Judith Navarro, [4]Joan Albanell, [5]Ana Rovira, [6]Federico Rojo, [7]Javier Oliver [Full author list]OncoImmunology [curation]DOI: 10.1080/2162402X.2015.1065370
PubMed: 26942084
2015-07-01
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer[1]Óscar Aguilera, [2]Jose Manuel Gonzalez Sancho, [3]Sandra Zazo, [4]Raúl Rincón, [5]Agustin F. Fernandez, [6]Olga Tapia, [7]Francesc Canals, [8]Beatriz Morte, [9]Vincenzo Calvanese, [10]Jose L Orgaz, ..., [21]Carlos López Otín, [22]Miguel Lafarga, [23]Federico Rojo, [24]Alberto Muñoz [Full author list]Oncotarget [curation]DOI: 10.18632/ONCOTARGET.3464
PubMed: 25788273
colorectal cancer [curation]; biomarker [curation]; colorectal carcinoma [curation]2015-03-01
HER2 as a target in invasive urothelial carcinoma[1]Joaquim Bellmunt, [2]Lillian Werner, [3]Aristotle Bamias, [4]André P Fay, [5]Rachel S Park, [6]Markus Riester, [7]Shamini Selvarajah, [8]Justine A Barletta, [9]David Berman, [10]Silvia de Muga, [11]Marta Salido, [12]Enrique Gallardo, [13]Federico Rojo, [14]Elizabeth A Guancial, [15]Richard Bambury, [16]Stephanie A Mullane, [17]Toni K Choueiri, [18]Massimo Loda, [19]Edward Stack, [20]Jonathan E Rosenberg [Full author list]Cancer Medicine [curation]DOI: 10.1002/CAM4.432
PubMed: 25720673
2015-02-26
PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects[1]Raúl Rincón, [2]Ion Cristóbal, [3]Sandra Zazo, [4]Oriol Arpí, [5]Silvia Menéndez, [6]Rebeca Manso, [7]Ana Lluch, [8]Pilar Eroles, [9]Ana Rovira, [10]Joan Albanell, [11]Jesús García-Foncillas, [12]Juan Madoz-Gúrpide, [13]Federico Rojo [Full author list]Oncotarget [curation]DOI: 10.18632/ONCOTARGET.3012
PubMed: 25726524
doxorubicin [curation]2015-02-01
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer[1]Javier Martinez-Useros, [2]Maria Rodriguez-Remirez, [3]Aurea Borrero-Palacios, [4]Irene Moreno, [5]Arancha Cebrian, [6]Teresa Gomez del Pulgar, [7]Laura del Puerto-Nevado, [8]Ricardo Vega-Bravo, [9]Alberto Puime-Otin, [10]Nuria Perez, [11]Sandra Zazo, [12]Clara Senin, [13]Mª Jesús Fernández-Aceñerp, [14]Marisol Soengas, [15]Federico Rojo, [16]Jesus Garcia-Foncillas [Full author list]BMC Cancer [curation]DOI: 10.1186/1471-2407-14-965
PubMed: 25515240
colorectal cancer [curation]2014-12-16
Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasis[1]Jelena Stanisavljević, [2]Jordina Loubat-Casanovas, [3]Mercedes Herrera, [4]Tomás Luque, [5]Raúl Peña, [6]Ana Lluch, [7]Joan Albanell, [8]Félix Bonilla, [9]Ana Rovira, [10]Cristina Peña, [11]Daniel Navajas, [12]Federico Rojo, [13]Antonio García de Herreros, [14]Josep Baulida [Full author list]Cancer Research [curation]DOI: 10.1158/0008-5472.CAN-14-1903
PubMed: 25488750
2014-12-08
Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy[1]Olga Pernía, [2]Cristobal Belda-Iniesta, [3]Veronica Pulido, [4]María Cortes-Sempere, [5]Carlos Rodriguez, [6]Olga Vera, [7]Javier Soto, [8]Julia Jiménez, [9]Alvaro Taus, [10]Federico Rojo, [11]Edurne Arriola, [12]Ana Rovira, [13]Joan Albanell, [14]M Teresa Macías, [15]Javier de Castro, [16]Rosario Perona, [16-Q73573863]Cristobal Belda Iniesta, [17]Inmaculada Ibañez de Caceres [Full author list]Epigenetics [curation]DOI: 10.4161/15592294.2014.971626
PubMed: 25482372
2014-11-01
Phosphorylated protein phosphatase 2A determines poor outcome in patients with metastatic colorectal cancer[1]I Cristóbal, [2]R Manso, [3]Raúl Rincón, [4]C Caramés, [5]S Zazo, [6]T G Del Pulgar, [7]A Cebrián, [8]J Madoz-Gúrpide, [9]Federico Rojo, [10]J García-Foncillas [Full author list]British Journal of Cancer [curation]DOI: 10.1038/BJC.2014.376
PubMed: 25003662
colorectal cancer [curation]; phosphorylation [curation]2014-07-08
Hyperphosphorylation of PP2A in colorectal cancer and the potential therapeutic value showed by its forskolin-induced dephosphorylation and activation[1]Ion Cristóbal, [2]Raúl Rincón, [3]Rebeca Manso, [4]Juan Madoz-Gúrpide, [5]Cristina Caramés, [6]Laura del Puerto-Nevado, [7]Federico Rojo, [8]Jesús García-Foncillas [Full author list]Biochimica et Biophysica Acta [curation]DOI: 10.1016/J.BBADIS.2014.06.032
PubMed: 24997451
colorectal cancer [curation]2014-07-02
High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients[1]Israel Cañadas, [2]Alvaro Taus, [3]Iria González, [4]Xavier Villanueva, [5]Javier Gimeno, [6]Lara Pijuan, [7]Manuel Dómine, [8]Albert Sánchez-Font, [9]Ivan Vollmer, [10]Silvia Menéndez, [11]Oriol Arpí, [12]Sergi Mojal, [13]Federico Rojo, [14]Ana Rovira, [15]Joan Albanell, [16]Edurne Arriola [Full author list]Oncotarget [curation]DOI: 10.18632/ONCOTARGET.2124
PubMed: 25026301
lung cancer [curation]2014-07-01
Deregulation of miR-200b, miR-200c and miR-429 indicates its potential relevant role in patients with colorectal cancer liver metastasis[1]Ion Cristóbal, [2]Raúl Rincón, [3]Rebeca Manso, [4]Cristina Caramés, [5]Oscar Aguilera, [6]Juan Madoz-Gurpide, [7]Federico Rojo, [8]Jesús García-Foncillas [Full author list]Journal of Surgical Oncology [curation]DOI: 10.1002/JSO.23661
PubMed: 24916918
colorectal cancer [curation]; liver metastasis [curation]; colorectal carcinoma [curation]2014-06-10
Clinical significance of miR-126 in colorectal cancer[1]Ion Cristóbal, [2]Oscar Aguilera, [3]Jesús García-Foncillas, [4]Sandra Zazo, [5]Juan Madoz-Gúrpide, [6]Federico Rojo [Full author list]Genes, Chromosomes and Cancer [curation]DOI: 10.1002/GCC.22192
PubMed: 24898922
colorectal cancer [curation]2014-06-04
Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma[1]Asunción Fernández-Barral, [2]Jose L Orgaz, [3]Pablo Baquero, [4]Zaheer Ali, [5]Alberto Moreno, [6]María Tiana, [7]Valentí Gómez, [8]Erica Riveiro-Falkenbach, [9]Carmen Cañadas, [10]Sandra Zazo, [11]Corine Bertolotto, [12]Irwin Davidson, [13]José Luis Rodríguez-Peralto, [14]Ignacio Palmero, [15]Federico Rojo, [16]Lasse D Jensen, [17]Luis del Peso, [18]Benilde Jiménez [Full author list]Neoplasia [curation]DOI: 10.1016/J.NEO.2014.06.001
PubMed: 25030625
2014-06-01
Potential involvement of protein phosphatase 2A in temsirolimus-mediated resensitization to cetuximab in colon cancer cells[1]Ion Cristóbal, [2]Rebeca Manso, [3]Raúl Rincón, [4]Juan Madoz-Gúrpide, [5]Cristina Caramés, [6]Federico Rojo, [7]Jesús García-Foncillas [Full author list]Journal of Cancer Research and Clinical Oncology [curation]DOI: 10.1007/S00432-014-1707-2
PubMed: 24828260
cetuximab [curation]; colon cancer [curation]2014-05-15
Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy[1]L del Puerto-Nevado, [2]Federico Rojo, [3]S Zazo, [4]C Caramés, [5]G Rubio, [6]R Vega, [7]C Chamizo, [8]V Casado, [9]J Martínez-Useros, [10]Raúl Rincón, [11]M Rodríguez-Remírez, [12]A Borrero-Palacios, [13]I Cristóbal, [14]J Madoz-Gúrpide, [15]O Aguilera, [16]J García-Foncillas [Full author list]British Journal of Cancer [curation]DOI: 10.1038/BJC.2014.225
PubMed: 24786599
metastatic renal cell carcinoma [curation]2014-05-01
Downregulation of miR-214 is specific of liver metastasis in colorectal cancer and could play a role determining the metastatic niche[1]Ion Cristóbal, [2]Cristina Caramés, [3]Juan Madoz-Gúrpide, [4]Federico Rojo, [5]Oscar Aguilera, [6]Jesús García-Foncillas [Full author list]International Journal of Colorectal Disease [curation]DOI: 10.1007/S00384-014-1872-4
PubMed: 24760176
colorectal cancer [curation]; liver metastasis [curation]2014-04-24
Up-regulation of c-Cbl suggests its potential role as oncogene in primary colorectal cancer[1]Ion Cristóbal, [2]Rebeca Manso, [3]Raúl Rincón, [4]Cristina Caramés, [5]Juan Madoz-Gúrpide, [6]Federico Rojo, [7]Jesús García-Foncillas [Full author list]International Journal of Colorectal Disease [curation]DOI: 10.1007/S00384-014-1839-5
PubMed: 24525700
colorectal cancer [curation]2014-02-15
The Crc protein inhibits the production of polyhydroxyalkanoates in Pseudomonas putida under balanced carbon/nitrogen growth conditions[1]Ruggero La Rosa, [2]Fernando de la Peña, [3]María Axiliadora Prieto, [4]Federico Rojo, [5]Fernando Rojo [Full author list]Environmental Microbiology [curation]DOI: 10.1111/1462-2920.12303
PubMed: 24118893
polyhydroxyalkanoate [curation]; Pseudomonas putida [curation]; colorectal carcinoma [curation]2013-11-06
Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer[1]Julia Inglés-Esteve, [2]Mònica Morales, [3]Alba Dalmases, [4]Ricard Garcia-Carbonell, [5]Alba Jene-Sanz, [6]Núria López-Bigas, [7]Mar Iglesias, [8]Cristina Ruiz-Herguido, [9]Ana Rovira, [10]Federico Rojo, [11]Joan Albanell, [12]Roger Gomis, [13]Anna Bigas Salvans, [14]Lluís Espinosa [Full author list]PLOS One [curation]DOI: 10.1371/JOURNAL.PONE.0038347
PubMed: 22675457
NF-κB [curation]2012-05-31
MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines[1]Edurne Arriola, [2]I Cañadas, [3]M Arumí-Uría, [4]M Dómine, [5]J A Lopez-Vilariño, [6]O Arpí, [7]M Salido, [8]S Menéndez, [9]E Grande, [10]F R Hirsch, [11]S Serrano, [12]B Bellosillo, [13]Federico Rojo, [14]A Rovira, [15]J Albanell [Full author list]British Journal of Cancer [curation]DOI: 10.1038/BJC.2011.298
PubMed: 21847116
phosphorylation [curation]; lung small cell carcinoma [curation]2011-08-16
Correct Q number of author item for selected works.
NO replacement author: revert to author name strings

Common author items in these papers

Common names in these papers


Feedback
Source and documentation (at github)
Wikidata page